28. Development of separation technology for targeted thorium conjugate formulations. Part II, Sequential DOE, MLR, PLS

Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part II: purification of targeted thorium conjugates on cation exchange columns

Janne Olsen Frenvik, Knut Dyrstad, Solveig Kristensen & Olav B. Ryan

To cite this article: Janne Olsen Frenvik, Knut Dyrstad, Solveig Kristensen & Olav B. Ryan (2017): Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part II: purification of targeted thorium conjugates on cation exchange columns,

Drug Development and Industrial Pharmacy, DOI: 10.1080/03639045.2017.1318906 To link to this article: http://dx.doi.org/10.1080/03639045.2017.1318906